| Literature DB >> 31117949 |
Johanna Brodhagen1, Rosemarie Weikard1, Ulrike Thom1, Annika Heimes1, Juliane Günther1, Frieder Hadlich1, Holm Zerbe2, Wolfgang Petzl2, Marie M Meyerholz2, Martina Hoedemaker3, Hans-Joachim Schuberth4, Susanne Engelmann5,6, Christa Kühn7,8.
Abstract
BACKGROUND: In the mammary gland transcriptome of lactating dairy cows genes encoding milk proteins are highly abundant, which can impair the detection of lowly expressed transcripts and can bias the outcome in global transcriptome analyses. Therefore, the aim of this study was to develop and evaluate a method to deplete extremely highly expressed transcripts in mRNA from lactating mammary gland tissue.Entities:
Keywords: Lactation; Mammary gland; Mastitis; RNA depletion; RNA-sequencing
Mesh:
Substances:
Year: 2019 PMID: 31117949 PMCID: PMC6530097 DOI: 10.1186/s12864-019-5781-3
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Fig. 1Workflow for RNase H- mediated RNA depletion of highly abundant transcripts
Fig. 2Effect of RNase H-mediated depletion of highly abundant transcripts on targeted genes in the mammary gland of lactating cows monitored by RT-qPCR analysis. a Ratio of antisense oligonucleotides in the RNA depletion mix according to the abundance of targeted genes as expected from other studies and b Higher, and identical concentration of antisense oligonucleotides in the RNA depletion mix (see Materials and Methods)
Fig. 3Average proportion of targeted milk protein transcripts in the mammary gland transcriptome with and without depletion in challenged and non-challenged udder samples of three cows, Without RNA depletion (0), with RNA depletion by variant A (A) and B (B). Variant A and B differ in antisense oligonucleotide input for depletion (see Materials and Methods)
Read statistic of raw data, after quality trimming and read alignment to the bovine genome
| Udder quarter treatment | Animal No. | Sample treatmenta |
|
|
|
|
|---|---|---|---|---|---|---|
| Non-challenged | Cow1 | 0 | 7.7 | 77,920,096 | 90 | 98 |
| A | 4.9 | 70,975,008 | 77 | 97 | ||
| B | 4.6 | 81,396,012 | 91 | 98 | ||
| Cow2 | 0 | 7.8 | 78,859,264 | 90 | 98 | |
| A | 4.9 | 80,349,800 | 90 | 98 | ||
| B | 5.4 | 78,824,666 | 89 | 98 | ||
| Cow3 | 0 | 8.1 | 80,203,836 | 90 | 99 | |
| A | 5.1 | 62,510,886 | 89 | 98 | ||
| B | 5.6 | 74,101,514 | 89 | 98 | ||
| Challenged | Cow1 | 0 | 7.9 | 78,564,210 | 90 | 98 |
| A | 4.7 | 78,719,102 | 90 | 98 | ||
| B | 4.9 | 80,990,200 | 89 | 98 | ||
| Cow2 | 0 | 9.6 | 92,966,426 | 89 | 98 | |
| A | 5.9 | 63,610,608 | 88 | 95 | ||
| B | 6.9 | 70,529,798 | 89 | 97 | ||
| Cow3 | 0 | 7.8 | 85,090282 | 89 | 98 | |
| A | 6.0 | 81,278,402 | 89 | 98 | ||
| B | 5.7 | 88,169,812 | 89 | 98 |
Pathogen challenged and non-challenged udder tissue samples of the cows 1–3, each of them without RNA depletion (0) and with RNA depletion variant A (A) or variant B (B). Variant A and B differ in antisense oligonucleotide input for depletion (see Materials and Methods)
Percentage of fragments mapped to individual milk protein transcripts in relation to the total number of fragments in each sample as counted by featureCounts [50]
| Udder quarter treatment | Animal No. | Sample treatmenta |
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|
| Non-challenged | Cow1 | 0 | 2.7 | 15.7 | 11.5 | 31.1 | 4.2 | 5.5 |
| A | 3.1 | 17.9 | 0.6 | 9.6 | 0.3 | 4.5 | ||
| B | 2.6 | 12.2 | 0.2 | 8.7 | 0.2 | 5.9 | ||
| Cow2 | 0 | 0.8 | 18.7 | 9.6 | 14.3 | 4.9 | 3.9 | |
| A | 0.5 | 18.7 | 0.8 | 3.1 | 0.1 | 2.2 | ||
| B | 0.4 | 16.4 | 0.2 | 2.8 | 0.1 | 2.0 | ||
| Cow3 | 0 | 1.0 | 16.7 | 9.5 | 21.6 | 4.9 | 7.4 | |
| A | 1.0 | 14.3 | 0.7 | 4.2 | 0.1 | 5.2 | ||
| B | 0.8 | 11.6 | 0.1 | 3.8 | 0.1 | 5.0 | ||
| Challenged | Cow1 | 0 | 1.1 | 15.2 | 11.1 | 21.9 | 3.3 | 4.3 |
| A | 1.0 | 12.1 | 0.6 | 5.9 | 0.1 | 3.8 | ||
| B | 0.9 | 9.0 | 0.2 | 5.4 | 0.0 | 4.0 | ||
| Cow2 | 0 | 0.4 | 12.3 | 7.5 | 6.3 | 2.1 | 4.2 | |
| A | 0.2 | 6.2 | 0.2 | 2.2 | 0.0 | 1.8 | ||
| B | 0.2 | 4.5 | 0.0 | 1.4 | 0.0 | 1.7 | ||
| Cow3 | 0 | 0.0 | 0.1 | 0.5 | 0.1 | 0.0 | 0.0 | |
| A | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| B | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 |
aUdder tissue samples without RNA depletion (0), with RNA depletion by variant A (A) or variant B (B). Variant A and B differ in antisense oligonucleotide input for depletion (see Materials and Methods)
Fig. 4Fragment abundance (in FPKM) per exon of the PAEP gene for depleted (protocol variants A and B) and non-depleted (0) RNA samples from E. coli challenged and non-challenged udder quarters for all cows included in the challenge experiment. For cow 3 challenged, almost no milk protein gene expression was observed: see y axis scale of the inserted diagram
Fig. 5Correlation plot of mean gene expression level (in log10 FPKM) between depleted and non-depleted RNA samples within E. coli challenged and non-challenged udder samples across animals investigated. 0, A, and B represent the non-depleted or the depleted RNA samples (protocol variant A and B), respectively
Fig. 6Effect of RNA depletion on transcriptome expression levels (mean and standard deviation within expression categories). Expression categories are classified in quartiles according to the transcription level based on average FPKM values across samples from challenged and non-challenged udder quarters. Sample treatment: no RNA depletion (0), RNA depletion variant A (A) or RNA depletion variant B (B). Variants A and B differ in antisense oligonucleotide input for RNA depletion (see Materials and Methods)
Number of expressed genes with FPKM > 1 and of genes with changed FPKM values after selective RNA depletion for all groups based on the Ensembl 87 reference annotation
| Groupsa | All genes with FPKM > 1 | Genes with FPKM > 1 only after RNA depletion | Genes with FPKM > 1 before and FPKM < 1 after RNA depletion |
|---|---|---|---|
| 0 | 12,546 | / | / |
| A | 12,773 | 554 | 315 |
| B | 12,817 | 582 | 304 |
aSamples without RNA depletion (0) and with RNA depletion according to variants A (A) and B (B). Variants A and B differ in antisense oligonucleotide input for RNA depletion (see Materials and Methods)
Fig. 7Number of pathways enriched for significantly differentially expressed genes after E. coli challenge in depleted (A and B) and non-depleted (0) udder tissue samples. Variant A and B differ in antisense oligonucleotide input for RNA depletion (see Materials and Methods)
Differential expression obtained from RNAseq data for selected genes in non-challenged udder samples compared to E. coli challenged samples
| Gene | q-value1 | ||
|---|---|---|---|
| 02 | A2 | B2 | |
|
| 0.092 | 0.019 | 0.002 |
|
| 0.662 | 0.289 | 0.002 |
|
| 0.057 | 0.019 | 0.004 |
|
| 0.096 | 0.036 | 0.002 |
|
| 0.189 | 0.200 | 0.022 |
|
| 0.124 | 0.051 | 0.024 |
1 Statistical significance (q value) for differential expression between infected and non-infected samples
2Udder tissue samples without RNA depletion (0), with RNA depletion according to variants A (A) and B (B). Variants A and B differ in antisense oligonucleotide input for depletion (see Materials and Methods)
Fig. 8Differential expression analysis testing immune genes for response to pathogen challenge. Results from RT-qPCR for the IL6 and CCL20 genes in response to E. coli challenge: samples from challenged (filled boxed) and non-challenged (open boxes) udder samples of three cows. Variants A and B differ in antisense oligonucleotide input for RNA depletion (see Materials and Methods), while 0 comprises the non-depleted RNA. *: p < 0.05, **: p < 0.01, ***: p < 0.001, †: p < 0.10
Number of all expressed loci and the subset of unknown expressed loci based on a group-specific transcriptome annotation
| Groupsa | All loci | All loci with FPKM > 1 | Unknown loci | Unknown loci with FPKM > 1 |
|---|---|---|---|---|
| 0 | 32,434 | 16,168 | 4411 | 1915 |
| A | 43,331 | 19,396 | 11,023 | 2997 |
| B | 35,510 | 17,779 | 6343 | 2509 |
aSamples without RNA depletion (0) and with RNA depletion according to variants A (A) and B (B). Variants A and B differ in antisense oligonucleotide input for depletion (see Materials and Methods)
Antisense oligonucleotide sequences designed for targeting highly abundant transcripts in the mammary gland
| Gene name | Accession number | Oligonucleotide name | Oligonucleotide sequence (5′-3′) |
|---|---|---|---|
|
| NM_173929.3 | LGB_R5 | GGGCTCACCTAGATGTGGCACTGCTC |
| LGB_R6 | GCTCAGCACTGTTCTCCATGCAGAAG | ||
|
| NM_174378.2 | LALBA_R6 | GTCATCAGTAAGATCATCATCCAGGAAC |
| LALBA_R7 | CAGAACAGAGTGCTTTATGGGCCAACC | ||
|
| NM_174528.2 | CSN1S2_R3 | ATAACCAGGTAGAAGCAGTTAATTCCAG |
| CSN1S2_R4 | ATGCTGGTTGTATGAAGTAAAGTGGTAG | ||
|
| NM_181029.2 | CSN1S1_R7 | TCAGAATTCACTTGACTCCTCACCACAG |
| CSN1S1_R8 | TAGGATTAGGGATGTCAGAGAATGATGG | ||
|
| NM_174294.2 | CSN3_R6 | GTAAGAGGAGACGAGGAAGGAGCCAG |
| CSN3_R7 | ACTGTGTTGATCTCAGGTGGGCTCTC | ||
|
| XM_010806178.1 | CSN2_R4 | TCCAGTCGCAGTCAATTCAAAAGTGAG |
| CSN2_R5 | CTTTCTGGGGAACAGGCAGGACTTTG |
Final concentration of the antisense oligonucleotides in the RNA depletion assays
| Oligonucleotide pair | Concentration [μM] | |
|---|---|---|
| Variant A | Variant B | |
| LGB_R5, LGB_R6 | 16.66 | 25.0 |
| LALBA_R6, LALBA_R7 | 16.66 | 25.0 |
| CSN1S2_R3, CSN1S2_R4 | 8.33 | 25.0 |
| CSN1S1_R7, CSN1S1_R8 | 16.66 | 25.0 |
| CSN3_R6, CSN3_R7 | 9.0 | 25.0 |
| CSN2_R4, CSN2_R5 | 25.0 | 25.0 |
Sequences of primers used in RT-qPCR
| Gene name | Gene accession number | Oligonucleotide name | Oligonucleotide sequence (5′-3′) |
|---|---|---|---|
|
| NM_173929.3 | LGB_F1 | CAAGATCCCTGCGGTGTTCAAG |
| LGB_R1 | ACTGTTCTCCATGCAGAAGAGC | ||
|
| NM_174378.2 | LALBA_F2 | CAGTTTGCCTGAATGGGTCT |
| LALBA_R3 | GATCATCATCCAGGAACTTGTC | ||
|
| NM_174528.2 | CSN1S2_F2 | CACCAGTGAGGAAAATTCAAAG |
| CSN1S2_R1 | GCTGATAAACAGTCTTGAGATAC | ||
|
| NM_181029.2 | CSN1S1_F4 | GTGCTGAGGAACGACTTCACAG |
| CSN1S1_R4A | CAGTGTATTGTGTGCCTAGTGG | ||
|
| NM_174294.2 | CSN3_F5 | GCCCACCTGAGATCAACACAG |
| CSN3_R5 | AGGAGACGAGGAAGGAGCCAG | ||
|
| XM_010806178.1 | CSN2_F1 | TGAGGAACAGCAGCAAACAG |
| CSN2_R1 | ACAGGGGTTTGAGTAAGAGG | ||
|
| NM_001037443.1 | RPS15A_F1 | CCGTGCTCCAAAGTCATCGTC |
| RPS15A_R1 | TGAAACCAAACTGACGGGATG | ||
|
| NM_174263.2 | CCL20_F3 | CAGCAAGTCAGAAGCAAGCAA |
| CCL20_R1 | CCCACTTCTTCTTTGGATCTGC | ||
|
| NM_173923.2 | IL6_F1 | GGAGGAAAAGGACGGATGCT |
| IL6_R1 | GGTCAGTGTTTGTGGCTGGA | ||
|
| NM_174581.2 | PPP1CC_F1 | TCGACAGCATCATCCAACG |
| PPP1CC_R1 | CGGGAAACCACCGTACTCA |